Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Pimicotinib Demonstrates Best-in-Class Potential with Significant Efficacy and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumor
-
McDermott Publishes 2024 Sustainability Report
-
The Latino Donor Collaborative Releases Preliminary Numbers from Part One of the 2025 Official LDC U.S. Latino GDP Report™: U.S. Latino Economy Hits $4 Trillion, Surpassing UK and India
-
Performance Food Group Company Hosts Investor Day Webcast; Reaffirms Fiscal 2025 Guidance; Sets 3-Year Targets; Announces New $500 Million Share Repurchase Program
-
Chargebacks911 Appoints Donald Kossmann as CTO to Lead AI-Driven Innovation in Payments
-
GTCR Announces Sale of Antylia Scientific
-
MindMed to Participate in June Investor Conferences
-
Papa Johns to Participate in the Oppenheimer 25™ Annual Consumer Growth and E-Commerce Conference
-
Medable Introduces Long-Term Follow-Up Model for Cell & Gene Therapy (CGT) Trials to Reduce Costs and Improve Patient Access
-
Luna Atoms' The Future: An AI-Powered Pop Rebellion Uniting Humanity
-
Gatik’s Brenda Mejia Honored Among 100 Leading Women in the North American Auto Industry
-
Gap Widens between Highest- and Lowest-Performing Employer-Sponsored Health Plans, J.D. Power Finds
-
Strand Therapeutics Announces Initial First-in-human Phase 1 Data for STX-001 in Patients with Advanced Solid Tumors at The 2025 ASCO Annual Meeting
-
Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology
-
Avacta Therapeutics Announces Appointments of Industry Veterans to Board of Directors
-
Worksport Secures ISO 9001 Certification at U.S. Factory, Unlocking Revenue & OEM Growth Pathways
-
Axsome Therapeutics Presents Data from Three of Its Innovative Neuroscience Programs at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
-
Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
-
Newton Golf Company (NASDAQ: NWTG) Regains Compliance with Nasdaq Listing Requirements
-
Contentstack Appoints Josette Leslie as Chief Financial Officer to Fuel Market Expansion
-
Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results
-
Triple Hair Group Strengthens Leadership Team with Appointment of Paul Sowyrda to its Board of Directors
-
NASA Visits Constellium Ravenswood to Celebrate Artemis Partnership
-
Photronics Reports Second Quarter Fiscal 2025 Results and Announces CEO Transition
-
Marketing and Sales Agency Stream Creative Featured in Google’s Annual Economic Impact Report
-
Entrada Therapeutics Receives Authorization in the European Union to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in Patients Living with Duchenne Muscula
-
Verve Therapeutics to Participate in Upcoming Investor Conferences
-
Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting
-
OTC Markets Group Welcomes Magna Mining Inc. to OTCQX
-
Balchem Corporation to Present at the Wells Fargo Industrials and Materials Conference on June 11, 2025
-
TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference
-
Avacta Therapeutics Announces Appointments of Industry Veterans to Board of Directors
-
Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split
-
Infosys Launches Agentic AI Foundry, Part of Infosys Topaz™, to Accelerate Enterprise AI Journey
-
Garmin revolutionizes aviation charting with SmartCharts
-
Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
-
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference
-
Form 8.5 (EPT/RI) - H & T Group Plc
-
Everstream Reaches Agreement for Sale of Business to Bluebird Fiber
-
Macy’s, Inc. Reports First Quarter 2025 Results
-
Bristol Myers Squibb Receives European Commission Approval for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications
-
SunCoke Energy, Inc. Enters Into Definitive Agreement to Acquire Phoenix Global
-
Global Payments Announces Agreement to Divest Payroll Business
-
YieldMax™ ETFs Announces Distributions on CVNY, CONY, YMAG, YMAX, ULTY, and Others
-
Form 8.5 (EPT/RI) - Inspired Plc
-
Velocity comes out of stealth with $10M to power the Velocity of Money
-
INE Security and RedTeam Hacker Academy Announce Partnership to Advance Cybersecurity Skills in the Middle East
-
BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
-
Early Warning Report Issued Pursuant to National Instrument 62-103 in Respect of Vinland Lithium Inc. Becoming a Reporting Issuer
-
GameStop Announces Purchase of Bitcoin


